Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
435 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03117036 | Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study III | recruiting | — | 600 | Samsung Medical CenterOTHER | 1 | May 21, 2025 | clinicaltrials |
| NCT06552572 | Glofitamab in Relapsed or Refractory Diffuse Large B-cell Lymphoma After CD19 Chimeric Antigen Receptor T-cell Therapy(Glory) | active not recruiting | Phase 2 | 30 | Samsung Medical CenterOTHER | 1 | May 21, 2025 |
| clinicaltrials |
| NCT06981689 | Association of Breast Reconstruction Method With Long-term Risk of Psychiatric Disorders | completed | — | 24,930 | Samsung Medical CenterOTHER | 0 | May 21, 2025 | clinicaltrials |
| NCT04738786 | Clinical Study Evaluating the Proper Surgical Safety Margin for Early Stage Oral Tongue Cancers | terminated | N/A | 125 | Samsung Medical CenterOTHER | 1 | May 18, 2025 | clinicaltrials |
| NCT04967417 | Pembrolizumab With Standard Cytotoxic Chemotherapy in Treatment Naive NSCLC Patients With Asymptomatic Brain Metastases(PHOEBS) | completed | Phase 2 | 13 | Samsung Medical CenterOTHER | 1 | May 9, 2025 | clinicaltrials |
| NCT05742438 | Effects of Dexmedetomidine/Lidocaine/Intrathecal Morphine on Cancer Metastasis Biomarker After Colorectal Surgery | completed | N/A | 114 | Samsung Medical CenterOTHER | 1 | Apr 2, 2025 | clinicaltrials |
| NCT06281054 | Acute Myocardial Infarction in Cancer Patients | active not recruiting | — | 4,500,000 | Samsung Medical CenterOTHER | 1 | Mar 14, 2025 | clinicaltrials |
| NCT06763042 | Usability and Utility of Mindfulness-based Life Management Social Robots for Children and Adolescents in the Long-term Treatment | completed | N/A | 50 | Samsung Medical CenterOTHER | 1 | Jan 8, 2025 | clinicaltrials |
| NCT03239613 | Postoperative Hypofractionated Intensity-modulated Radiation Therapy with Concurrent Chemotherapy in Cervical Cancer | completed | N/A | 84 | Samsung Medical CenterOTHER | 1 | Jan 3, 2025 | clinicaltrials |
| NCT03239626 | Postoperative Hypofractionated Intensity-modulated Radiation Therapy in Cervical Cancer | active not recruiting | N/A | 120 | Samsung Medical CenterOTHER | 1 | Jan 3, 2025 | clinicaltrials |
| NCT04819243 | PALbociclib Endocrine Therapy Followed by Talazo Vs. Talazoz-Atezo Study(Young-PALETTA) | recruiting | Phase 2 | 178 | Samsung Medical CenterOTHER | 1 | Jan 3, 2025 | clinicaltrials |
| NCT06729684 | Development and Validation of a Personalized Digital Healthcare Model for Managing Side Effects in Breast Cancer Survivors | recruiting | N/A | 72 | Samsung Medical CenterOTHER | 1 | Dec 11, 2024 | clinicaltrials |
| NCT03134456 | Pembrolizumab for Metastatic NSCLC Patients Expressing PD-L1 Who Have Their Own PDX | completed | Phase 4 | 50 | Samsung Medical CenterOTHER | 1 | Dec 3, 2024 | clinicaltrials |
| NCT05453682 | Hypofractionated IMRT With Concurrent Chemotherapy in Muscle-invasive Bladder Cancer (HIRACUM)(HIRACOM) | recruiting | N/A | 53 | Samsung Medical CenterOTHER | 1 | Dec 2, 2024 | clinicaltrials |
| NCT06703957 | The Samsung Medical Center Comprehensive Cancer Center Registry from 2008 to 2023(SCCCR08-23) | completed | — | 301,055 | Samsung Medical CenterOTHER | 1 | Nov 25, 2024 | clinicaltrials |
| NCT04678544 | Cooling Cap Trial to Prevent Permanent Chemotherapy-induced Alopecia in Breast Cancer Patients | completed | N/A | 170 | Samsung Medical CenterOTHER | 1 | Nov 5, 2024 | clinicaltrials |
| NCT06509724 | Comparison of Conventional and Hypofractionated IMRT in High-Risk Cervical Cancer Post-Radical Hysterectomy(POHIM-P3) | recruiting | Phase 3 | 248 | Samsung Medical CenterOTHER | 1 | Jul 26, 2024 | clinicaltrials |
| NCT04798820 | The Effect of Intensive Dietary Education on Nutritional Status After Gastrectomy(SING)(SING) | unknown | N/A | 358 | Samsung Medical CenterOTHER | 1 | Jul 15, 2024 | clinicaltrials |
| NCT06461793 | Safety of Dose Escalation in Definitive Hypofractionated Radiation Therapy and Hormone Therapy With SpaceOAR TM for Patients With High - Risk Localized Prostate Cancer (DESAR-H)(DESAR-H) | recruiting | Phase 2 | 33 | Samsung Medical CenterOTHER | 1 | Jun 21, 2024 | clinicaltrials |
| NCT06461819 | Safety of Dose Escalation in Definitive Hypofractionated Radiation Therapy With SPACEOAR TM for Patients With Low-to-intermediate Risk Localized Prostate Cancer (DESAR-L)(DESAR-L) | recruiting | Phase 2 | 33 | Samsung Medical CenterOTHER | 1 | Jun 21, 2024 | clinicaltrials |
| NCT06467097 | Systemic Treatment Alone Versus Systemic Treatment Plus Radiotherapy in Oligometastatic Renal Cell Carcinoma(SABLOR) | recruiting | Phase 3 | 88 | Samsung Medical CenterOTHER | 1 | Jun 20, 2024 | clinicaltrials |
| NCT05876130 | Postoperative Hypofractionated Intensity-modulated Radiotherapy Endometrial Cancer | recruiting | N/A | 92 | Samsung Medical CenterOTHER | 1 | Jun 12, 2024 | clinicaltrials |
| NCT03705546 | The Impact of Physical Activity on the Postoperative Symptoms, Complications, and Quality of Life Among Lung Cancer | unknown | — | 1,050 | Samsung Medical CenterOTHER | 1 | May 24, 2024 | clinicaltrials |
| NCT03306901 | Chemoradiotherapy Versus Esophagectomy After Endoscopic Resection for Superficial Esophageal Squamous Cell Carcinoma(ASSURE) | active not recruiting | N/A | 240 | Samsung Medical CenterOTHER | 1 | May 23, 2024 | clinicaltrials |
| NCT05260606 | Imaging Biomarkers for Immune Checkpoint Inhibitor Treatment in Patients With Non-small Cell Lung Cancer(IBFIC) | unknown | — | 100 | Samsung Medical CenterOTHER | 1 | Apr 17, 2024 | clinicaltrials |
| NCT06357000 | Time From PCI to Cancer Surgery and Cardiovascular and Oncologic Outcomes | completed | — | 3,621 | Samsung Medical CenterOTHER | 0 | Apr 10, 2024 | clinicaltrials |
| NCT06200233 | Rivoceranib in Patients With Metastatic Thymic Epithelial Tumor | not yet recruiting | Phase 2 | 40 | Samsung Medical CenterOTHER | 1 | Apr 9, 2024 | clinicaltrials |
| NCT06330012 | The Resistance Mechanism of Trastuzumab Deruxtexan in HER2 Positive Breast Cancer Patients. | recruiting | N/A | 50 | Samsung Medical CenterOTHER | 1 | Mar 26, 2024 | clinicaltrials |
| NCT06330870 | Brain Metastasis Development Mechanism in BCBM Patients | recruiting | N/A | 30 | Samsung Medical CenterOTHER | 1 | Mar 26, 2024 | clinicaltrials |
| NCT04249739 | Pembrolizumab + Capecitabine／Oxaliplatin (CapeOx) -HER2 Nagative and Pembrolizumab + Trastuzumab + Cisplatin/Capecitabine HER2 Positive | unknown | Phase 2 | 93 | Samsung Medical CenterOTHER | 1 | Mar 13, 2024 | clinicaltrials |
| NCT06259162 | LAG3 Expression in Triple Negative Breast Cancer | recruiting | N/A | 128 | Samsung Medical CenterOTHER | 1 | Feb 14, 2024 | clinicaltrials |
| NCT06195904 | Genomic Profiling of Pancreatic Cystic Tumors | not yet recruiting | — | 250 | Samsung Medical CenterOTHER | 1 | Jan 8, 2024 | clinicaltrials |
| NCT03066297 | Optimal Extent of Pulmonary Resection in Clinical Stage IA Non-Small Cell Lung Cancer(OREX-IA) | active not recruiting | — | 1,018 | Samsung Medical CenterOTHER | 1 | Dec 6, 2023 | clinicaltrials |
| NCT03241537 | COHORT Trial in Clinical Pelivc Lymph Node Metastatic Prostate Cancer | active not recruiting | Phase 3 | 61 | Samsung Medical CenterOTHER | 1 | Nov 27, 2023 | clinicaltrials |
| NCT03269981 | Randomized Study of Elective Regional Lymph Node Irradiation in N1 Breast Cancer | active not recruiting | N/A | 827 | Samsung Medical CenterOTHER | 1 | Nov 27, 2023 | clinicaltrials |
| NCT03822728 | Intra-parotid Facial Nerve Imaging in Parotidectomy | completed | N/A | 270 | Samsung Medical CenterOTHER | 1 | Nov 27, 2023 | clinicaltrials |
| NCT01910909 | Stereotactic Body Radiotherapy for Unresectable Hepatocellular Carcinoma(SBRT for HCC) | completed | N/A | 56 | Samsung Medical CenterOTHER | 1 | Nov 22, 2023 | clinicaltrials |
| NCT02571946 | Proton Beam Therapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis(PTHP) | completed | N/A | 53 | Samsung Medical CenterOTHER | 1 | Nov 22, 2023 | clinicaltrials |
| NCT03637569 | The Relationship Between Triceps Skinfold and Overall Survival of Pancreas, Bile Duct, Gallbladder Cancer | recruiting | — | 1,000 | Samsung Medical CenterOTHER | 1 | Aug 25, 2023 | clinicaltrials |
| NCT05955521 | Exosome as the Prognostic and Predictive Biomarker in EBC Patients | active not recruiting | N/A | 200 | Samsung Medical CenterOTHER | 1 | Jul 21, 2023 | clinicaltrials |
| NCT05910710 | Impact of Immuno-Oncologic Agent on Neoadjuvant Chemotherapy in Triple Negative Breast Cancer | unknown | — | 50 | Samsung Medical CenterOTHER | 1 | Jun 20, 2023 | clinicaltrials |
| NCT05907642 | Effects of Dried Plum (Prune) Intake on the Incidence of Low Anterior Resection Syndrome in Patients With Rectal Cancer | completed | N/A | 65 | Samsung Medical CenterOTHER | 1 | Jun 18, 2023 | clinicaltrials |
| NCT05872334 | The Safety and Feasibility of MONOFIX on Fascial Closure of Mid-line Wound After Minimally Invasive Colorectal Cancer Surgery | completed | N/A | 120 | Samsung Medical CenterOTHER | 1 | May 24, 2023 | clinicaltrials |
| NCT03618667 | GC1118 in Recurrent Glioblastoma Patients With High EGFR Amplification | completed | Phase 2 | 13 | Samsung Medical CenterOTHER | 1 | May 12, 2023 | clinicaltrials |
| NCT04792749 | Clinical Effects of Metformin on Fertility-sparing Treatment for Early Endometrial Cancer | unknown | Phase 3 | 77 | Samsung Medical CenterOTHER | 1 | Apr 13, 2023 | clinicaltrials |
| NCT03991403 | Study of Atezolizumab Combination Carboplatin + Paclitaxel + Bevacizumab in EGRF Mutation or ALK Translocation NSCLC | unknown | Phase 3 | 228 | Samsung Medical CenterOTHER | 1 | Apr 3, 2023 | clinicaltrials |
| NCT04649671 | The Effect of Mobile Health-based Exercise on Hepatocellular Carcinoma Patients With Insulin Resistance | terminated | N/A | 15 | Samsung Medical CenterOTHER | 1 | Mar 6, 2023 | clinicaltrials |
| NCT05701384 | Lazertinib 160mg in EGFR T790M NSCLC | unknown | Phase 2 | 117 | Samsung Medical CenterOTHER | 1 | Jan 27, 2023 | clinicaltrials |
| NCT05078918 | Comprehensive Care Program for Their Return to Normal Life Among Lung Cancer Survivors | unknown | N/A | 800 | Samsung Medical CenterOTHER | 1 | Nov 21, 2022 | clinicaltrials |
| NCT05431244 | Pilot Study of Antiviral Treatment in Combination With Low-dose Gemcitabine in EBV-associated Gastric Cancer (EBVaGC) | withdrawn | N/A | 0 | Samsung Medical CenterOTHER | 1 | Nov 1, 2022 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials